• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
PMV Pharma released FY2025 9 Months earnings on November 12, 2025 (EST), actual revenue: USD 0, actual EPS: USD -1.1408
04:00
PMV Pharma released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3973 (forecast USD -0.4025)
04:00
Nov12
TD Cowen Maintains Buy Rating on PMV Pharmaceuticals Stock
16:07
Oct27
OrbiMed Advisors LLC Reports Sale of PMV Pharmaceuticals Inc. Common Stock
21:20
Aug8
PMV Pharma released FY2025 Q2 earnings on August 7 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.4077 (forecast USD -0.385)
03:00
PMV Pharma released FY2025 Semi-Annual earnings on August 7 (EST), actual revenue USD 0, actual EPS USD -0.7434
03:00

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -21.06 M, EPS -0.3973

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -21.21 M, EPS -0.4077

May9
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -17.44 M, EPS -0.3356

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SMX
377.730
+167.89%
+236.730
TGL
13.830
+104.65%
+7.072
WHLR
6.143
+89.60%
+2.920
TDIC
0.4059
+44.55%
+0.126
IRBT
4.245
+40.10%
+1.219
PRAX
251.445
+32.36%
+61.475
DBRG
12.750
+31.17%
+3.025
CHPT
10.870
+27.58%
+2.340
YYAI
1.320
+26.92%
+0.280
TORO
5.180
+25.41%
+1.050
View More